SEOUL, Samsung Biologics Co. on Wednesday reported its 2023 net profit of 857.7 billion won (US$641.5 million), up 7.5 percent from a year earlier. Operating income for the year was 1.11 trillion won, up 13.2 percent on-year, the company said in a regulatory filing. Annual sales rose 23.1 percent to 3.69 trillion won. Source: Yonhap News Agency
Myanmar Clears Path for Junta Leader to Become President
March 30, 2026